Ignite Creation Date:
2025-12-24 @ 5:34 PM
Ignite Modification Date:
2026-05-13 @ 9:46 AM
Study NCT ID:
NCT05005468
Status:
UNKNOWN
Last Update Posted:
2021-08-13
First Post:
2021-08-05
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase II Trial of Camrelizumab Combined With Famitinib for Adjuvant Treatment of Stage II-IIIA NSCLC.
Sponsor:
Organization: